Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GATA-2 Project: Retrospective and Prospective Exploratory Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

NCT05983991 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT05983991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05983991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GATA-2 Project: Retrospective and Prospective Exploratory Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Recruiting
Start date
December 7, 2023
Completion date
December 31, 2033
Enrollment
150 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

gata2 gene mutation